Radiopharmaceutical therapy in cancer: clinical advances and challenges

G Sgouros, L Bodei, MR McDevitt… - Nature reviews Drug …, 2020 - nature.com
Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach
to treating many types of cancer. In RPT, radiation is systemically or locally delivered using …

Human serum albumin: from bench to bedside

G Fanali, A Di Masi, V Trezza, M Marino… - Molecular aspects of …, 2012 - Elsevier
Human serum albumin (HSA), the most abundant protein in plasma, is a monomeric multi-
domain macromolecule, representing the main determinant of plasma oncotic pressure and …

Single domain camel antibodies: current status

S Muyldermans - Reviews in molecular Biotechnology, 2001 - Elsevier
The antigen-binding capacity of the paired variable domains of an antibody is well
established. The observation that the isolated heavy chains of anti-hapten antibodies retain …

Dual variable domain immunoglobin and uses thereof

C Wu, T Ghayur, RW Dixon, JG Salfeld - 2007 - Google Patents
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O= C ([C@ H](CO) NC
(= O)[C@ H](CC (C) C) NC (= O)[C@ H](CC (O)= O) NC (= O)[C@ H](CC (C) C) NC …

[HTML][HTML] Pros and cons of different therapeutic antibody formats for recombinant antivenom development

AH Laustsen, JM Gutiérrez, C Knudsen, KH Johansen… - Toxicon, 2018 - Elsevier
Antibody technologies are being increasingly applied in the field of toxinology. Fuelled by
the many advances in immunology, synthetic biology, and antibody research, different …

Antibody engineering

J Maynard, G Georgiou - Annual review of biomedical …, 2000 - annualreviews.org
▪ Abstract Antibodies are unique in their high affinity and specificity for a binding partner, a
quality that has made them one of the most useful molecules for biotechnology and …

Tumor targeting by an aptamer

BJ Hicke, AW Stephens, T Gould… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Aptamers are small oligonucleotides that are selected to bind tightly and specifically to a
target molecule. We sought to determine whether aptamers have potential for in vivo …

Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors

RA Beckman, LM Weiner, HM Davis - Cancer, 2007 - Wiley Online Library
Whereas over 85% of human cancers are solid tumors, of the 8 monoclonal antibodies
(mAbs) currently approved for cancer therapy, 25% are directed at solid tumor surface …

Antibody vectors for imaging

T Olafsen, AM Wu - Seminars in nuclear medicine, 2010 - Elsevier
Noninvasive molecular imaging approaches include nuclear, optical, magnetic resonance
imaging, computed tomography, ultrasound, and photoacoustic imaging, which require …

Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin

L Borsi, E Balza, M Bestagno… - … journal of cancer, 2002 - Wiley Online Library
We recently demonstrated that a human recombinant scFv, L19, reacting with the ED‐B
domain of fibronectin, a marker of angiogenesis, selectively targets tumoral vasculature in …